Results 81 to 90 of about 3,233,658 (249)

Lipid Lowering Drugs all have a place in therapy

South African Family Practice, 1992
No abstract available.
SAFPJ Editor
doaj   +1 more source

Azobenzene's Cross‐Scale Optics and Photonics: Molecular Photoswitching, Mesoscopic Material Motions, and Adaptive Devices

Advanced Materials, EarlyView.
Azobenzene photoswitches translate molecular‐scale E/Z photoisomerization into macroscopic material responses and device‐level photonic functions. This Review highlights how azobenzene research has evolved from molecular photochemistry to photoalignment, mass migration, photomechanics, and heat release, ultimately enabling holography, reconfigurable ...
Heeju Son, Soyul Kwak, Heerin Noh, Minsang Kim, Doyeon Noh, Subhayan Chakraborty, Jaewon Lee, YongDeok Cho, Kyeongsoo Kim, Taewoong Eom, Moonyoung Kim, Jangwon Kim, Hoyoung Lee, Soyoung Lee, Jaehun Kim, Grace G. D. Han, Shin‐Tson Wu, Stefano Oscurato, Arri Priimagi, Marina Saphiannikova, Seungwoo Lee   +20 more
wiley   +1 more source

The “Chinese Dose” of statin

Cardiology Plus, 2016
The benefits of atherosclerotic cardiovascular disease prevention/treatment and lipid-lowering therapy come from the reduction of cholesterol itself. However, based on safety considerations, all guidelines note that high-intensity statin therapy is not ...
Ping Ye
doaj   +1 more source

Safety of significant, long-term lipid lowering therapy. Focus on inclisiran, with Braunwald's vision

High blood cholesterol is one of the most important risk factors of atherosclerosis. Currently, four groups of drugs (statins, ezetimibe, PCSK9 inhibitors and bempedoic acid) have large clinical trials proving that the frequency of cardiovascular events ...
László Márk
core   +1 more source

Lipid-lowering medications and plasma lipids.

, 2019
Effect of lipid-lowering medication usage on a) concentrations (mmol) of cholesterol, LDL-C and HDL-C, triglycerides and HLR ...
Russell Pickford (4092991), John Attia (103776), Matthew Wai Kin Wong (6490733), Nady Braidy (261733), Henry Brodaty (158887), Julia Muenchhoff (6490736), Anne Poljak (158842), Fatemeh Vafaee (2851946), John Crawford (158850), Peter Schofield (311568), Perminder Sachdev (377263)   +10 more
core   +1 more source

Replication of LDL SWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses [PDF]

, 2011
<p><b>Background:</b> The PHArmacogenetic study of Statins in the Elderly at risk (PHASE) is a genome wide association study in the PROspective Study of Pravastatin in the Elderly at risk for vascular disease (PROSPER) that investigates
Jukema, J.W., Buckley Brendan M, Postmus Iris, Devlin James J, Trompet, S., Muriel Caslake, Sattar, N., Sacks Frank, Anton JM de Craen, Ford Ian, Ian Ford, Ford, I., Trompet Stella, Caslake Muriel, Sattar Naveed, David J Stott, Slagboom, P.E., Slagboom P, James J Devlin, Caslake, M., de Craen Anton JM, Buckley, B.M., Stott David J, P Eline Slagboom, Devlin, J.J., Westendorp, R.G.J., Craen, A.J.M. de, de Craen, A.J.M., J Wouter Jukema, Postmus, I., Jukema J, Stella Trompet, Frank Sacks, Naveed Sattar, Sacks, F., Westendorp Rudi GJ, null null, Iris Postmus, Rudi GJ Westendorp, Brendan M Buckley, PROSPER Study Grp, Stott, D.J.   +41 more
core   +2 more sources

Polyphenol‐Inspired Materials for Agricultural Applications

Advanced Materials, EarlyView.
This review outlines the use of polyphenol‐inspired materials for sustainable agriculture, highlighting their molecular design, interfacial assembly, structure–property relationships, and prospects toward precision agriculture, climate resilience, ecosystem protection, and circular bioeconomy strategies.
Haofu Liu, Omid Mazaheri, Zhixing Lin, Tianzheng Wang, Jingqu Chen, Yuang Gu, Xia Liang, Deli Chen, Frank Caruso   +8 more
wiley   +1 more source

Ten-year Risk of Atherosclerotic Cardiovascular Disease Predicts Long-Term Mortality in Lipid-Lowering Therapy

, 2023
Background: The 10-year risk of atherosclerotic cardiovascular disease (ASCVD) can be effectively estimated by the ASCVD Risk Score derived from the pooled cohort equations.
Shirani, Jamshid, Ma, Zhiyuan, Moran, Lynn N   +2 more
core   +1 more source

Nuclear Pore Mechanotransduction in Oncology: A Structural Axis of Vulnerability for Targeted Intervention

Advanced Materials, EarlyView.
Cancer‐associated NPC remodeling creates a high‐flux, low‐stringency nuclear state that supports malignant adaptation but increases mechanical fragility. Targeting the FG‐barrier or NPC scaffold may drive mechanostat failure, envelope rupture, DNA damage, and loss of nuclear integrity.
Sílvio Terra Stefanello, Caren Rigon Mizdal, Aline Franzen da Silva, Yun Qian, Wei‐En Yuan, Victor Shahin   +5 more
wiley   +1 more source

Adherence to lipid-lowering treatment: the patient perspective

, 2012
Manuela Casula,1 Elena Tragni,1 Alberico Luigi Catapano1,21Epidemiology and Preventive Pharmacology Centre (SEFAP), Department of Pharmacological Sciences, University of Milan, Milan, Italy; 2IRCCS MultiMedica, Sesto San Giovanni, ItalyAbstract: Despite ...
Casula M, Tragni E, Catapano AL
core